id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0231-0010,FDA,FDA-2011-N-0231,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2018-06-08T04:00:00Z,2018,6,2018-06-08T04:00:00Z,,2023-09-07T21:07:07Z,2018-12338,0,0,090000648337b830
FDA-2011-N-0231-0009,FDA,FDA-2011-N-0231,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Adverse Experience Reporting for Licensed Biological Products; and General Records,Notice,30 Day Proposed Information Collection,2018-01-08T05:00:00Z,2018,1,2018-01-08T05:00:00Z,2018-02-08T04:59:59Z,2023-09-07T21:06:53Z,2018-00095,0,0,0900006482db13e0